Interactive Transcript
0:00
Let's take a look at this lung cancer screening CT
0:03
and a 75-year-old woman with a 40 pack year history
0:06
of cigarette smoking with 14 years since quit,
0:10
so still remains eligible under the 15 years since quit.
0:14
Criterion, she's asymptomatic,
0:16
but she delayed her lung cancer screening due
0:19
to the Covid pandemic.
0:20
She had been screened earlier in 2019, in the summer June,
0:25
and now comes in February, 2021
0:28
for her lung cancer screening.
0:30
You can see from the top of the lungs the not uncommon,
0:33
mild, upper and mid lung predominant central lobular
0:36
emphysema that we see in patients
0:37
with a cigarette smoking history.
0:40
It's a little bit of fullness here in the right hilum,
0:43
but I see some calcification through the lung windows.
0:46
A little bit of loation here
0:48
that we don't expect at this location.
0:51
Let's keep looking small airways.
0:54
Don't look particularly thick, don't see any moid impaction,
0:58
and a little bit of mild dependent ectasis,
1:02
which we know we see more common in people as they age
1:05
and in individuals who smoke versus those who don't.
1:09
Um, let's look at the soft tissue windows a little bit noisy
1:14
as we expect due to the low dose exam.
1:17
As we come to the level of aortic arch here,
1:21
we're seeing an enlarged lymph node in the right
1:23
parit tracheal region.
1:25
If we measure it in short axis diameter,
1:28
we're getting 21 millimeters.
1:29
So that definitely meets the criteria
1:31
for an enlarged lymph node
1:34
and we see more enlarged lymph nodes here in the right parit
1:36
tracheal region here next to the aorta.
1:40
And that right hilum is bothering me
1:42
because it's lobulated in an area
1:44
where there shouldn't be any loation.
1:46
The pulmonary vessels aren't coming out yet.
1:48
They're a little bit lower down here,
1:51
and there's this fullness here behind the SVC,
1:54
we see normal mediastinal fat around the ascending UTA
1:58
and interdigitating here in the Precarinal area,
2:01
but right here where we expect to see the SVC,
2:04
there's not any fat behind it.
2:06
So I'm concerned about this area here.
2:09
Admittedly, it's very hard on a non-contrast CT to look
2:12
for hilar lymph nodes,
2:14
particularly when they're just mildly enlarged.
2:16
If we have a comparison
2:18
and can compare the shape
2:19
of the hilum today versus the shape of the past
2:22
and see a change, that can be a clue when
2:24
you have a first time ct.
2:25
It's a big challenge to identify enlarged hilar nodes,
2:29
particularly the mildly enlarged ones.
2:32
So we already have a non pulmonary finding.
2:35
We didn't come across a lung nodule,
2:37
but we did find this extra pulmonary finding
2:40
of enlarged mediastinal
2:42
and potentially right hial lymph nodes.
2:44
So next thing we're gonna do is we're gonna look
2:46
for her baseline ct.
2:48
And on the left here was her prior lung cancer screening CT
2:53
from June, 2019.
2:56
She had normal size right para tracheal node back
2:58
Then under a centimeter, just normal sized
3:03
and we could see a little bit more fat
3:04
behind the SVC than we can see now.
3:08
And so it looks like the enlarged lymph nodes are new,
3:10
definitely in the para tracheal region.
3:12
A bit softer column on the right hilum, so not a nodule.
3:16
So no nodule criteria to put it in. Lung RADS 2 3 4 4 A.
3:21
But we have an extra pulmonary findings
3:24
and I'm concerned about this being malignancy.
3:26
So this is a lung RADS four x, not
3:28
because of nodule features, but
3:30
because of extra pulmonary features.
3:33
This patient goes on to get a pet CT
3:35
and you can see the enlarged lymph nodes in the right per
3:38
tracheal region and down into the right hilum are all very
3:41
FDG avid and there similarly was no signal coming from the
3:46
lung as being a source.
3:48
Those patients subsequently underwent a bronchoscopy
3:52
with AL aspiration through the bronchoscope
3:56
of the right para tracheal
3:58
lymph nodes demonstrating poorly differentiated
4:01
pulmonary adenocarcinoma.
4:03
Even though like I said, we can't see the primary.
4:06
Thus cellular makeup of the tumor is consistent
4:09
with a pulmonary adenocarcinoma.
4:11
This is a stage three A cancer.
4:14
Fortunately for this patient, there was a high intensity
4:18
of the PD L one mutation 70%.
4:21
So in addition to receiving traditional chemo
4:23
and radiation therapy, the patient qualified for one
4:27
of the immunotherapies
4:28
that are targeted based on the PD L one mutation.
4:32
So she has a pembrolizumab treatment
4:34
and had a very good response to tumor treatment
4:38
and shrinkage of the tumor subsequently.
4:41
So here we have that extra pulmonary finding
4:44
of enlarged lymph nodes.
4:45
PET positive new finding since
4:47
of prior CT making this four x
4:49
and was the reason for the diagnosis
4:51
of lung cancer in this patient.